Foley Hoag advised Butterfly Network, while DLA Piper advised the underwriters on the offering. Butterfly Network, Inc. (NYSE: BFLY), a digital health company, announced the registered...
Butterfly Network’s $86.9 Million Common Stock Offering
Elicio Therapeutics’ US$40 Million ATM and US$11.5 Million Public Offering
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Elicio, while DLA Piper advised JonesTrading Institutional Services (Jones), as agent and as sole book-running manager in the...
Zealand Pharma’s US$1 Billion Equity Offering
DLA Piper acted as US counsel to Zealand Pharma on the offering. Zealand Pharma, a Danish biotechnology company focused on the discovery and development of peptide-based...
Redx Pharma’s Merger with Jounce Therapeutics
Cooley advised Redx Pharma on the deal while Ropes & Gray has advised Jounce Therapeutics, Inc. Redx Pharma, a UK clinical-stage biotechnology company, announced its all share...